CICC signs nutriceutical products distribution agreement with Beijing Eastern Union Biopharmaceuticals, Ltd.

SHENZHEN, China, January 31, 2014 /PRNewswire/ -- On January 27, 2014, China Internet Cafe Holdings Group Inc. ("CICC" or the "Company") (OTCQB: CICC), a leading chain of Internet cafes in the People's Republic of China, announced that it signed a distribution agreement with Beijing Eastern Union Biopharmaceuticals, Ltd. ("BEUB"), a leading pharmaceutical and nutriceutical products manufacturer in China, to distribute nutriceutical products including Melatonin tablets, Vitamin B tablets, Calcium and Zinc chewable tablets and multi-vitamin tablets through CICC's 62 cafe locations in Shenzhen, southern China. These nutriceutical products will soon be placed into CICC's 62 cafe locations after the Chinese New Year.

"We're pleased to work with Beijing Eastern Union Biopharmaceuticals, Ltd. and distribute BEUB's nutriceutical products in our internet cafes." Said Mr. Dishan Guo, Chairman and CEO of CICC, "Together with BEUB, we will provide the best nutriceutical products with the lowest price in China to our 2 million active members and their families."

About China Internet Cafe Holdings Group Inc. ("CICC")

CICC, through its controlled entity, Junlong Culture Communication Co., Ltd., owns and operates a chain of Internet cafes in the People's Republic of China. It provides Internet access services, online games, movies, music, and online chatting software to its customers. Also, the Company sells snacks, drinks, third-party online gaming cards and cafe membership. It owns 62 Internet cafes and over 2 million members within the city of Shenzhen in Guangdong province. The Company was founded in 2003 and is based in Shenzhen, China.

About Beijing Eastern Union Biopharmaceuticals, Ltd. ("BEUB")

BEUB, founded in 2001 and headquartered in Beijing, is a leading private biopharmaceutical company engaged in the research, development, production and sale of pharmaceutical products, health products in China. The Company focuses on anti-tumor, diabetes, cardiovascular drugs and health products and sells its products through regional distributors, which cover 778 hospitals and clinics among 25 provinces in China.